全部商品分类.jpg)
1/2
产品介绍
产品介绍
产品信息
抗原名称
Aurora A (Human),Aurora B (Xenopus laevis),Aurora C (Human),MEK1,MEK2

商品描述
BI-847325 is an orally bioavailable, and selective dual <b>MEK/Aurora kinase</b> inhibitor with <b>IC50</b> of 3 nM, 25 nM, 15 nM, 25 nM, and 4 nM for Xenopus laevis Aurora B, human Aurora A and Aurora C, as well as human MEK1 and MEK2, respectively. Phase 1.

分子量
464.56

纯度
98%

可溶性
DMSO : 18 mg/mL (38.7 mM)
Ethanol : 1 mg/mL (2.15 mM)
Ethanol : 1 mg/mL (2.15 mM)

外观
Powder

In vitro(体外研究)
BI-847325 shows growth-inhibitory effects on BRAF-mutant and vemurafenib-resistant melanoma cells with IC50 ranging from 0.3 nM to 2 μM, and prevents colony formation in six BRAF-mutant melanoma cell lines. BI-847325 also induces apoptosis by reducing Mcl-1 expression.

In vivo(体内研究)
In mice bearing 1205Lu and 1205LuR xenografts, BI-847325 (75 mg/kg, p.o.) causes significant tumor suppression without significant alteration in the body weights.

背景
别名
BI 847325;BI847325

分子式
C29H28N4O2

CAS号
1207293-36-4

制备和贮存
保存方式
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
声明 :本官网所有报价均为常温或者蓝冰运输价格,如有产品需要干冰运输,需另外加收干冰运输费。







用小程序,查商品更便捷


